Market Cap 49.48M
Revenue (ttm) 2.91M
Net Income (ttm) -94.82M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -3,258.42%
Debt to Equity Ratio 0.04
Volume 2,100
Avg Vol 22,950
Day's Range N/A - N/A
Shares Out 2.51M
Stochastic %K 60%
Beta 1.82
Analysts Hold
Price Target $6.50

Latest News on OMIC

Singular Genomics Announces 1-for-30 Reverse Stock Split

Jun 21, 2024, 4:05 PM EDT - 7 months ago

Singular Genomics Announces 1-for-30 Reverse Stock Split


Singular Genomics: Betting On Expanding Genomics Systems Market

Feb 15, 2023, 8:38 AM EST - 2 years ago

Singular Genomics: Betting On Expanding Genomics Systems Market